Janux Therapeutics (JANX) Earnings Analysis
Janux Therapeutics (JANX) has no confirmed upcoming earnings date. Last quarter (2026-02-26) it beat with EPS -0.51 USD vs -0.65 USD est (+21.5%). It has beaten estimates in 3/4 recent quarters (75%). Trailing P/E -8.49.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does JANX next report earnings?
No confirmed upcoming earnings date is currently scheduled for JANX. This page updates as the calendar is published.
JANX earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-02-26 | -0.51 USD | -0.65 USD | +21.5% | Beat |
| 2025-11-06 | -0.39 USD | -0.6 USD | +35% | Beat |
| 2025-08-07 | -0.55 USD | -0.48 USD | -14.6% | Miss |
| 2025-02-27 | -0.36 USD | -0.49 USD | +26.5% | Beat |
Beat rate: 3/4 (75%) over reported quarters with consensus data.
JANX valuation and analyst view
| Trailing P/E | -8.49 |
|---|---|
| Trailing EPS | -1.8268 USD |
| Price / book | 1.04 |
| Dividend yield | 0.00% |
| Market cap | 0.96B |
| Analyst consensus | Buy (11 buy / 3 hold / 1 sell) |
| Avg price target | 28 USD |
Related research pages
Frequently asked questions
When is Janux Therapeutics (JANX)'s next earnings date?
No confirmed upcoming earnings date is currently scheduled for JANX. This page updates as the calendar is published.
Did JANX beat earnings last quarter?
In its 2026-02-26 report, JANX posted EPS of -0.51 USD versus a -0.65 USD estimate — a beat of 21.5%.
What is JANX's earnings track record?
Over the last 4 reported quarters with consensus data, JANX beat estimates 3 times (75%).
What is JANX's current P/E ratio and EPS?
JANX trades at a trailing P/E of -8.49 on trailing EPS of -1.826804279603152 USD.
What do analysts rate JANX?
Analyst consensus is "Buy" across 15 ratings (0 strong buy, 11 buy, 3 hold, 1 sell, 0 strong sell). Average 12-month price target: 28 USD.